NetworkNewsBreaks

TuesdayNov 16, 2021 9:30 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) Announces Strategic Appointment of World-Renowned Immunologist and Cytokine Expert

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has announced the appointment of Eleanor N. Fish, Ph.D., to its research and clinical advisory board. Dr. Fish is an accomplished researcher in the areas of immunology and inflammatory disorders and a member of the government of Canada’s expert scientific panel to the chief scientific advisor. She brings key expertise to FSD Pharma that will support the continued development of FSD-PEA, the company’s proprietary anti-inflammatory agent, and Lucid-MS, its drug candidate for the treatment of multiple sclerosis.…

Continue Reading

MondayNov 15, 2021 3:08 pm

NetworkNewsBreaks – Global Fiber Technologies Inc. (GFTX) Subsidiary Enters Partnership to Offer NFT, Vinyl Record Bundles

Global Fiber Technologies (OTC: GFTX) announced that its subsidiary, Authentic Heroes Inc., has inked a letter of intent (“LOI”) to create a joint venture with Maestro Entertainment Corp. The agreement outlines the terms of licensing Maestro’s music catalog of more than 10,000 master recordings as well as leveraging Maestro’s industry relationships to pursue opportunities for combined venue. According to the announcement, the agreement will create a synergy between the companies. Initial collaboration will include creating and selling non-fungible music tokens along with vinyl records that will be available individually or bundled together. Maestro Entertainmenthas acquired the rights to more than 16,000 master song recordings from the 1940s,…

Continue Reading

MondayNov 15, 2021 2:32 pm

NetworkNewsBreaks — Roth Capital Partners Announces 10th Annual Technology Event

Roth Capital Partners, a full-service investment bank that has built a reputation for serving emerging growth companies, will be hosting the upcoming 10th annual Roth Technology Event; the event will be held virtually this year and is scheduled for Nov. 17–18, 2021. The gathering is designed to create opportunities for investors to meet one-on-one with executive management teams from more than 75 private and public sector companies that have interest or are operating in tech subsectors. These 40-minute video meeting provide in-depth insights and allow extensive interaction between companies and potential investors. “We have always focused our conferences on enabling…

Continue Reading

MondayNov 15, 2021 2:10 pm

NetworkNewsBreaks – Tingo Inc. (IWBB) Reports Q3 Results

Tingo (OTC: IWBB), a leading agri-fintech business in Africa, has released its unaudited financial results for the three and nine months ended September 30, 2021. Worth noting is that, on a proforma basis, IWBB’s wholly owned subsidiary, Tingo Mobile PLC, totaled revenues of $177 million and $317.5 million and operating income of $82 million and $170.2 million for the three and nine month periods, respectively. In addition, the report noted that as a percentage of overall revenue, income generated from Tingo’s NWASSA marketplace platform reached $56.5 million and $120.7 million for the three and nine months ended September 30, 2021; both figures…

Continue Reading

MondayNov 15, 2021 1:46 pm

NetworkNewsBreaks – OTC Markets Group Inc. (OTCM) Featured in Research Note from Sidoti

Price Target Raised; Earnings Release OTC Markets Group Inc. (OTCQX: OTCM) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “OTCM Delivers Impressive 3Q:21 Results Leading To EPS Beat And Estimate Raise; Announces Significant Increase To Year-End Special Dividend: Raise Price Target To $60 (From $50).” Click here to access the full report. About OTC Markets Group Inc. OTC Markets Group operates the OTCQX(R) Best Market, the OTCQB(R) Venture Market and the Pink(R) Open Market for 11,000 U.S. and global securities. Through OTC Link(R) ATS and OTC Link ECN, we connect…

Continue Reading

MondayNov 15, 2021 1:21 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2 2022 Financial, Business Report

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, has reported its financial and business updates for the second quarter of FY2022, the period ended Sept. 30, 2021. Notable highlights include the launch of Miboko, the company’s beta mass-market metabolic health program and the signing of a global commercial contract with MySugarWatch DuoPack Limited (“MSW-DP”). In addition, the company named Dr. Osama Hamdy, MD and PhD., as a new consultant on its advisory board as a consultant. Regarding the financial report, the company reported total operating expenses…

Continue Reading

MondayNov 15, 2021 1:03 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch delivery and monitoring device, software and data platform with Ei.Ventures’ proprietary psychedelic formulations. In addition, the two companies will work together on advancing Ei.Ventures’ research and development strategy. The partnership takes the two companies a step closer to negotiating and finalizing certain definitive research and…

Continue Reading

MondayNov 15, 2021 12:34 pm

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Featured in Equity Research Report

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, was featured in a recent equity research report. The coverage, initiated by Maxim Group LLC, highlights MINDCURE’s efforts to set the stage to unlock value for the company. This includes work on its ongoing programs and clinical development, including synthetic ibogaine, for which it is planning a preclinical study with its research partner to initially conduct cardiac and neurological screens with data and potentially move into behavioral studies. In addition, the company plans to schedule a pre-IND meeting for its…

Continue Reading

MondayNov 15, 2021 12:33 pm

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Uniquely Positioned in Cancer Screening, Detection Market

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is the company behind a proprietary novel technology for early cancer screening and detection — the Cancer Differentiation Analysis (“CDA”). Powered by a database containing over 200,000 samples and cases, AnPac Bio’s CDA technology can detect and carry multifaceted information, including cellular and protein-level details, to determine the existence of cancerous environments. At present, the company’s CDA platform “can detect up to 26 different types of cancer, which gives AnPac Bio a major advantage over industry peers in terms of cost effectiveness, multi-cancer testing, ability…

Continue Reading

MondayNov 15, 2021 12:20 pm

NetworkNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Committed to Making Psychedelic Wellness Accessible to the Masses

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, is well positioned to capitalize on the psychedelic industry’s continued growth trajectory. “The company owns and operates a self-sustaining ecosystem of businesses in the psychedelic space consisting of media, science and health business verticals. Delic has been particularly active on the mergers and acquisitions front over the last several months in a bid to further broaden the company’s business horizons,” reads a recent article. In March, the company acquired the brand and IP of Homestead, a legacy counterculture distributor of psychedelic media and creator of one of the first…

Continue Reading